Abstract
Aerogels are the 3D network of organic, inorganic, composite, layered, or hybrid-type
materials that are used to increase the solubility of Class 1 (low solubility and high permeability)
and Class 4 (poor solubility and low permeability) molecules. This approach improves systemic
drug absorption due to the alveoli's broad surface area, thin epithelial layer, and high vascularization.
Local therapies are more effective and have fewer side effects than systemic distribution
because inhalation treatment targets the specific location and raises drug concentration in the
lungs.
The present manuscript aims to explore various aspects of aerogel formulations for pulmonary
targeted delivery of active pharmaceutical agents. The manuscript also discusses the safety, efficacy,
and regulatory aspects of aerogel formulations. According to projections, the global respiratory
drug market is growing 4–6% annually, with short–term development potential. The proliferation
of literature on pulmonary medicine delivery, especially in recent years, shows increased
interest.
Aerogels come in various technologies and compositions, but any aerogel used in a biological
system must be constructed of a material that is biocompatible and, ideally, biodegradable. Aerogels
are made via "supercritical processing". After many liquid phase iterations using organic
solvents, supercritical extraction, and drying are performed. Moreover, the sol-gel polymerization
process makes inorganic aerogels from TMOS or TEOS, the less hazardous silane. The resulting
aerogels were shown to be mostly loaded with pharmaceutically active chemicals, such as
furosemide-sodium, penbutolol-hemisulfate, and methylprednisolone. For biotechnology, pharmaceutical
sciences, biosensors, and diagnostics, these aerogels have mostly been researched.
Although aerogels are made of many different materials and methods, any aerogel utilized in a
biological system needs to be made of a substance that is both biocompatible and, preferably,
biodegradable.
In conclusion, aerogel-based pulmonary drug delivery systems can be used in biomedicine and
non-biomedicine applications for improved sustainability, mechanical properties, biodegradability,
and biocompatibility. This covers scaffolds, aerogels, and nanoparticles. Furthermore, biopolymers
have been described, including cellulose nanocrystals (CNC) and MXenes. A safety
regulatory database is necessary to offer direction on the commercialization potential of aerogelbased
formulations. After that, enormous efforts are discovered to be performed to synthesize an
effective aerogel, particularly to shorten the drying period, which ultimately modifies the efficacy.
As a result, there is an urgent need to enhance the performance going forward.
Keywords:
Aerogel, pulmonary drug delivery, sol-gel process, biocompatibility, safety and efficacy, regulatory, scaffolds.
Graphical Abstract
[22]
Schwertfeger, F.; Zimmermann, A.; Krempel, H. Use of inorganic aerogels in pharmacy. United States Patent US 6,280,744, 2001.
[26]
Berg, A.; Droege, M.W.; Fellmann, J.D.; Klaveness, J.; Rongved, P. Medical use of organic aerogels and biodegradable organic aerogels. EP Patent 0707474A1, 1995.
[28]
Lee, K.P.; Gould, G.L. Aerogel Powder Therapeutic Agents; Aspen Publishers Aerogels Inc., 2001.
[29]
Kanamori, K. Aerogels; Klein, L.; Aparicio, M; Jitianu, A., Ed.; Springer International Publishing, 2016.
[31]
Lee, K.P.; Gould, G.L. Aerogel Powder Therapeutic Agents; Aspen Publishers Aerogels Inc., 2001.
[46]
Egu, J.; Moldován, K.; Herman, P.; István, F.; Kalmár, J.; Fenyvesi, F. 6ER-017 prevention of extravasation by the local application of hybrid aerogel microparticles as drug delivery systems for cervical cancer chemotherapy. BMJ, 2022, 29, A172.1-A1A172.
[48]
Del Castillo, A.M.P. Nanomaterials and Workplace Health & Safety: What Are the Issues for Worker?; European Trade Union Institute: Brussels, 2013.
[49]
Workplace Safety & Prevention Services, Silica in the Workplace;; Ontario, 2011.
[50]
Feldmann, K. D.; Musolin, K.; Methner, M. M. Evaluation of Aerogel Insulation Particulate at a Union Trading Facility; United States Department of Health and Human Services, Centers for Disease Control and Prevention & National Institute for Occupational Safety and Health 2015.
[51]
The Uk NanoSafety Partnership Group. Working Safely with Nanomaterials in Research & Development. Nano; Safety Partnership Group, 2012.
[54]
Seheult, J.N.; Costello, S.; Tee, K.C. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a diskus™ inhaler and baseline spirometric parameters: A cross-sectional study. Springerplus, 2021, 3, 496.
[59]
The European Commission. Commission Regulation (EU). Off. J. Eur. Union 2018/1881 of amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards, 2018 (L308), 4.12.2018, 1–20. 2018.
[60]
Occupational Exposure Limits in mg/M3; Vol. 8 hours TWA –
Respirable dust;; European Network on Silica: EU 27 + Norway &
Switzerland,, 2019.
[61]
Workplace Exposure Limits; 4th ed.; Health and Safety Executive, 2020.
[62]
Directive (EU) 2017/2398 of the European Parliament and of the Council of 12 December 2017 Amending Directive 2004/37/EC on the Protection of Workers from the Risks Related to Exposure to Carcinogens or Mutagens at Work - Document 32017L2398;; The European Parliament and Council, 2017.
[63]
Occupational Safety and Health Standards OSHA Laws & Regulations – Regulations (Standards – 29 CFR), 1910, 1910.1000. Occupational Safety and Health Administration, 1910, 3, 1910.
[66]
Feldmann, K. D.; Musolin, K.; Methner, M. M. Evaluation of Aerogel Insulation Particulate at a Union Trading Facility; United States Department of Health and Human Services, Centers for Disease Control and Prevention & National Institute for Occupational Safety and Health 2015.
[67]
Aegerter, M.A.; Leventis, N.; Koebel, M.M. Aerogel Handbook. In: Advances in Sol–Gel Derived Materials and Technologies; Aegerter, M.A.; Prassas, M., Eds.; Springer, 2011.
[82]
Rao, A.V. Superhydrophobic Silica Aerogels Based on Methyltrimethoxysilane Precursor. J. Non-Cryst. Solids, 2003, 330(1–3), 187-195.
[96]
Zhang, Y.; Lim, C.T.; Ramakrishna, S. Recent development of polymer nanofibers for biomedical and biotechnological applications. J. Mater, Medico. Mater. Sci., 2005, 16, 933-946.
[101]
Gunasekaran, L.X.; Eleya, M.M.O. Whey protein concentrate hydrogels as bioactive carriers. J. Appl. Polym. Sci., 2023, 140(46), 2470-2476.
[106]
ASTM F2792-12a.Standard Terminology for Additive Manufacturing Technologies; ASTM International: West, 2012.
[116]
Tetik, H. 3D freeze printing of functional aerogels. Doctoral Dissertation; Kansas State University,